NASDAQ:UTHR

United Therapeutics Stock Forecast

etoro logo Buy UTHR
*Your capital is at risk
$547.06
-5.42 (-0.98%)
At Close: Jul 10, 2026
AI Analysis AI Analysis of UTHR AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add UTHR to Watchlist?
Some Reasons Why To Add UTHR:
  • High gross margin of 86.6%
  • +85.1% price growth over the last year
  • Strong operating margin of 45.3%
PDF

United Therapeutics Corporation stock downgraded from Buy Candidate to Sell Candidate after Friday trading session
(Updated on Jul 10, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jul 10, 2026

The United Therapeutics Corporation stock price fell by -0.98% on the last day (Friday, 10th Jul 2026) from $552.48 to $547.06. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 2.51% from a day low at $539.88 to a day high of $553.44. The price has fallen in 6 of the last 10 days but is still up by 0.68% over the past 2 weeks. Volume has increased on the last day by 6 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 296 thousand shares were bought and sold for approximately $162.03 million.

The stock lies in the middle of a falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -6.50% during the next 3 months and, with a 90% probability hold a price between $493.22 and $531.30 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

UTHR Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, June 18, 2026, and so far it has risen 1.95%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The United Therapeutics Corporation stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $552.56 and $551.16. A break-up above any of these levels will issue buy signals. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for United Therapeutics Corporation stock

United Therapeutics Corporation finds support from accumulated volume at $544.33 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $13.56 between high and low, or 2.51%. For the last week the stock has had daily average volatility of 2.21%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (UTHR) For The Upcoming Trading Day Of Monday 13th

For the upcoming trading day on Monday, 13th we expect United Therapeutics Corporation to open at $546.79, and during the day (based on 14 day Average True Range), to move between $540.56 and $553.56, which gives a possible trading interval of +/-$13.00 (+/-2.40%) up or down from last closing price. If United Therapeutics Corporation takes out the full calculated possible swing range there will be an estimated 2.40% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $544.33 (0.50%) than the resistance at $549.87 (0.51%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is United Therapeutics Corporation stock A Buy?

United Therapeutics Corporation holds several negative signals and is within a falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

Current score: -1.695 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 13, 2026 - $546.79 ( 0.0487%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

UTHR Performance

Trading levels for UTHR

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 560.35 2.43%
R2 555.17 1.48%
R1 551.97 0.90%
Price 547.06
S1 541.61 -1.00%
S2 538.41 -1.58%
S3 533.23 -2.53%

Accumulated Volume Support & Resistance Levels

Level Price
R3 596.76 9.08%
R2 588.38 7.55%
R1 549.87 0.514%
Price 547.06
S1 544.33 -0.499%
S2 542.66 -0.80%
S3 536.59 -1.91%

FAQ

What is the symbol for United Therapeutics Corporation Stock and on which exchange is it traded?
The symbol for United Therapeutics Corporation is UTHR and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell United Therapeutics Corporation Stock?
United Therapeutics Corporation holds several negative signals and is within a falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

How to buy United Therapeutics Corporation Stock?
United Therapeutics Corporation Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy United Therapeutics Corporation Stock.

What's the current price of United Therapeutics Corporation Stock?
As of the end of day on the Jul 10, 2026, the price of an United Therapeutics Corporation (UTHR) share was $547.06.

What is the 52-week high and low for United Therapeutics Corporation Stock?
The 52-week high for United Therapeutics Corporation Stock is $609.35 and the 52-week low is $272.18.

What is the market capitalization of United Therapeutics Corporation Stock?
As of the Jul 10, 2026, the market capitalization of United Therapeutics Corporation is 23.221B.

When is the next earnings date for United Therapeutics Corporation?
The upcoming earnings date for United Therapeutics Corporation is Jul 29, 2026.
Click to get the best stock tips daily for free!
ABOUT UNITED THERAPEUTICS CORPORATION
United Therapeutics
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertension (PAH) to diminish symptoms associated with exercise; Tyvaso, an inhaled formulation of prostacyclin a...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
11.34% Jun 29
NMRK
$15.02
1.20% Jun 24
NESR
$25.07
14.16% Jun 23
CAG
$13.43
2.98% Jun 23
GIB
$66.69
0.555% Jun 12

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE